July 8, 2020
AHA and ISTH Outline VTE Research Priorities
July 8, 2020—The International Society on Thrombosis and Haemostasis (ISTH) and the American Heart Association (AHA) announced the release of a joint scientific statement identifying five top priorities for research on venous thromboembolism (VTE). The statement was published by Mary Cushman, MD, et al in ISTH’s Research and Practice in Thrombosis and Haemostasis and AHA’s Circulation.
According to the ISTH and AHA, the statement was developed by nine global hematology experts with survey data from 16 scientific organizations and encourages multidisciplinary approaches to solve important research barriers.
The societies advised that the joint statement provides a comprehensive guide to future research covering five levels of priorities. These include fundamental research, human research, patient research, practice level research, and community and population research. Examples of identified needs include the development of better preclinical models, new diagnostic approaches, risk assessments and treatments, defining the long-term health of VTE patients, and evaluating the impact of public awareness campaigns.
Dr. Cushman, the statement’s chair, commented in the announcement, “The research priorities detailed in the statement provide a foundation for basic scientists and clinical researchers to transform medical care for patients with VTE and improve outcomes. We hope that researchers, funding agencies, and the public globally will see the need for investing in solutions to address the significant public health impacts of VTE.”